FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288903796> ?p ?o ?g. }

• W4288903796 endingPage "1351" @default.
• W4288903796 startingPage "1337" @default.
• W4288903796 abstract "What is known and objective Bispecific drugs (BDs) belong to the family of immunotherapies along with checkpoint inhibitors and CAR-T cells. In the field of oncology, BDs are designed to simultaneously bind a tumour antigen on the one side and an antigen present on the surface of effector cells on the other. This review summarizes the information available to date on the first marketed BiTE-format bispecific antibody, blinatumomab BLINCYTO® in acute lymphoblastic leukaemia. Methods A literature search was conducted in the PubMed database by including studies published in English using the term blinatumomab. Furthermore, bibliographies of selected references were also evaluated for relevant articles. Clinical trial (CT) data were retrieved from clinicaltrials.gov (ongoing trials, adverse events [AEs]) and global pharmacovigilance data were retrieved from VigiBase®. Results and discussion Blinatumomab is a fusion protein which consists of two single-chain variable fragments arranged in tandem: the first binds the CD19 surface antigen of all B cells and the second targets the CD3 antigen of T cells. Binding of blinatumomab to B and T cells induces apoptosis of B cells after secretion of granzymes and perforins by T cells. T-cell activation results in secretion of pro-inflammatory cytokines and upregulation of activation markers and adhesion molecules on the surface of T cells. The major CTs that led to an indication show increased overall survival with blinatumomab with better efficacy in patients in haematological remission with minimal residual disease ≥10−3. The major AEs are cytokine release syndrome, neurotoxicity and hypogammaglobulinemia. The three most frequent system organ classes in CTs are haematological, gastrointestinal and general disorders. These results are also found in VigiBase® but neurological disorders and infections appear more frequently in real life. What is new and conclusion This review summarizes the current knowledge of blinatumomab in the literature. The subject of many CTs is to improve the route of administration and expand the indications for treatment." @default.
• W4288903796 created "2022-07-31" @default.
• W4288903796 creator A5027472830 @default.
• W4288903796 creator A5053131766 @default.
• W4288903796 creator A5056174328 @default.
• W4288903796 creator A5059752314 @default.
• W4288903796 creator A5070682331 @default.
• W4288903796 date "2022-07-29" @default.
• W4288903796 modified "2023-09-30" @default.
• W4288903796 title "The pharmacology of blinatumomab: state of the art on pharmacodynamics, pharmacokinetics, adverse drug reactions and evaluation in clinical trials" @default.
• W4288903796 cites W1510865194 @default.
• W4288903796 cites W1635229836 @default.
• W4288903796 cites W1656760840 @default.
• W4288903796 cites W1855117435 @default.
• W4288903796 cites W1880040018 @default.
• W4288903796 cites W1981179374 @default.
• W4288903796 cites W1987913042 @default.
• W4288903796 cites W1991644988 @default.
• W4288903796 cites W1996815863 @default.
• W4288903796 cites W2015988540 @default.
• W4288903796 cites W2024271337 @default.
• W4288903796 cites W2024470685 @default.
• W4288903796 cites W2026698098 @default.
• W4288903796 cites W2028120859 @default.
• W4288903796 cites W2030185161 @default.
• W4288903796 cites W2031089532 @default.
• W4288903796 cites W2031452426 @default.
• W4288903796 cites W2037873230 @default.
• W4288903796 cites W2038139667 @default.
• W4288903796 cites W2042329979 @default.
• W4288903796 cites W2049903909 @default.
• W4288903796 cites W2057463153 @default.
• W4288903796 cites W2060244206 @default.
• W4288903796 cites W2072449326 @default.
• W4288903796 cites W2081996016 @default.
• W4288903796 cites W2087640820 @default.
• W4288903796 cites W2088729407 @default.
• W4288903796 cites W2095426672 @default.
• W4288903796 cites W2107925822 @default.
• W4288903796 cites W2108486979 @default.
• W4288903796 cites W2118241155 @default.
• W4288903796 cites W2121402452 @default.
• W4288903796 cites W2125221295 @default.
• W4288903796 cites W2127516396 @default.
• W4288903796 cites W2128824801 @default.
• W4288903796 cites W2135363598 @default.
• W4288903796 cites W2149486731 @default.
• W4288903796 cites W2165968767 @default.
• W4288903796 cites W2166899683 @default.
• W4288903796 cites W2167882988 @default.
• W4288903796 cites W2178103997 @default.
• W4288903796 cites W2220679566 @default.
• W4288903796 cites W2259315062 @default.
• W4288903796 cites W2285430992 @default.
• W4288903796 cites W2325763885 @default.
• W4288903796 cites W2341237625 @default.
• W4288903796 cites W2346378690 @default.
• W4288903796 cites W2403074774 @default.
• W4288903796 cites W2485045656 @default.
• W4288903796 cites W2514115149 @default.
• W4288903796 cites W2525951487 @default.
• W4288903796 cites W2527615464 @default.
• W4288903796 cites W2540646728 @default.
• W4288903796 cites W2546276407 @default.
• W4288903796 cites W2582784681 @default.
• W4288903796 cites W2586167822 @default.
• W4288903796 cites W2591709377 @default.
• W4288903796 cites W2599899418 @default.
• W4288903796 cites W2614019261 @default.
• W4288903796 cites W2731354373 @default.
• W4288903796 cites W2744224321 @default.
• W4288903796 cites W2751085562 @default.
• W4288903796 cites W2751161351 @default.
• W4288903796 cites W2754849291 @default.
• W4288903796 cites W2755023221 @default.
• W4288903796 cites W2761529444 @default.
• W4288903796 cites W2764336914 @default.
• W4288903796 cites W2766479173 @default.
• W4288903796 cites W2767772214 @default.
• W4288903796 cites W2787145330 @default.
• W4288903796 cites W2800450014 @default.
• W4288903796 cites W2889815270 @default.
• W4288903796 cites W2904768891 @default.
• W4288903796 cites W2907116594 @default.
• W4288903796 cites W2913371460 @default.
• W4288903796 cites W2914292410 @default.
• W4288903796 cites W2951197612 @default.
• W4288903796 cites W2970052749 @default.
• W4288903796 cites W2982639572 @default.
• W4288903796 cites W2992270245 @default.
• W4288903796 cites W2993178565 @default.
• W4288903796 cites W3006232173 @default.
• W4288903796 cites W3007495084 @default.
• W4288903796 cites W3083588228 @default.
• W4288903796 cites W3093938683 @default.
• W4288903796 cites W3114544457 @default.
• W4288903796 cites W3131174609 @default.
• W4288903796 cites W3146837831 @default.

• next